Cookies on the Economic Times website

Economic Times has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings,we'll assume that you are happy to receive all cookies on the Economic Times website. However, you can change your cookie setting at any time by clicking on our Cookie Settings at any time.You can also see our Privacy Policy

When the pandemic hit, India's healthcare industry was quick to adapt to the need of the hour

Reuters

Synopsis

Indian diagnostic companies had experience in developing test assays for dengue, HIV, TB and H1N1, but with Covid-19 the delay in getting hold of the genetic code of SARS-Cov2 meant the Indian government, in the initial months of the pandemic, had to wait on imported RT-PCR kits that were expensive with worldwide shortage. In March, the Indian Council of Medical Research placed an order of one million probes from Germany.

NEW DELHI | MUMBAI: As countries scrambled to find medical essentials for front-line workers and patients fighting the pandemic, India’s healthcare entrepreneurs and industry stepped in to fill the shortage. From diagnostic makers developing RT-PCR testing kits in record time to manufacturers of personal protection equipment (PPE) and N95 masks, companies revamped assembly lines to expedite manufacturing.Indian diagnostic companies had

To Read the Full Story, Become an ET Prime Member

Access the exclusive Economic Times stories, Editorial and Expert opinion

Why

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise